Hosted on MSN11mon
FDA approves Takeda’s ENTYVIO SC for Crohn’s diseaseThe US Food and Drug Administration (FDA) has granted approval for Takeda’s ENTYVIO subcutaneous (SC) administration as a maintenance therapy to treat adults with moderately to severely active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback